BDAZ - It all sounds very simple then. We just need to produce some numbers in BETonMACE something thing like: All numbers were statistically significant, 52% reduction in CV death (p=.002), 42% RRR in non-fatal stroke (p=.004), 57% RRR in non-fatal MI (p=.001) with an overall RRR of 49% and we would be away to the races. Instead of designing and implementing another larg CVOT trial Novo Nordisk could just buy us for $16 billion and have it all paid for and bucket loads of profit before their trial would otherwise be finished.

Can you put a bug in their ear for us please.

tada